Location: San Diego, California
Cellistic will be attending the 11th Innate Killer Summit in San Diego, where Holly Gills will be onsite to exchange with teams developing NK-based therapies.
This meeting is a good opportunity to discuss a recurring challenge in Natural Killer cell therapy development: strong biological potential is often established early, while manufacturability and its impact on program planning, becomes visible much later.
What we'll be discussing
NK programs often advance with strong biology but limited visibility into how they will translate to clinical manufacturing.
We’ll exchange on how Cellistic’s pre-established Echo™-NK platform, spanning development through scalable GMP manufacturing, provides early clarity on expected yield, cost and development timeline.
Meet Holly
Holly Gills will be attending throughout the summit and available for meetings, coffee chats, or lunch discussions to explore how Cellistic could support your program.
If you’d like to connect during the event, feel free to signal your interest through the form below.